PRECISION BIOSCIENCES RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR PBGENE-HBV, A FIRST-IN-CLASS GENE EDITING THERAPY DESIGNED TO ELIMINATE THE ROOT CAUSE OF CHRONIC HEPATITIS B

Reuters · 2d ago

Please log in to view news